04.24.18
This market research report presents a detailed segmentation of the global cancer diagnostic devices market by product (companion diagnostics and molecular diagnostics), by cancer type (lung, breast, colorectal, prostate, cervical, and other cancer types), and by geography (the Americas, APAC, and EMEA). The leading vendors in this market are Abbott Diagnostics, Agilent Technologies, BD, bioMérieux, Qiagen, and Roche Diagnostics.
Get our latest research report on the Global Cancer Diagnostic Devices Market 2018-2025
Overview of the global cancer diagnostic devices market
PMR research analyst predicts that the global cancer diagnostic devices market will grow at a significant CAGR of over 18% during the forecast period. A key market driver powering the growth of the cancer diagnostic devices market is the need for cost-cutting by pharma companies. Pharmaceutical companies are shifting their focus from drug development to cancer diagnostic devices so that they can help in diagnosing, monitoring, and administering drugs through the cancer treatment process. These devices play a key role in helping pharmaceutical companies develop specific drugs to treat cancer. One such example is Roche’s cobas EGFR mutation test, which diagnoses head and neck cancers. Increased investment in diagnostic device development will boost market growth by the end of 2025.